
Company Info
Year Established2018
Ticker
IMVT
Exchange
NASDAQ
Contacts
Eric Venker, M.D., Pharm. DCEO
Company Description
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases.